Vidia
VIDIA Ltd. is a private Czech biotechnological company. It was founded in 1991 by experienced research scientists. VIDIA is the IVD producer of diagnostic kit for human medicine and for environmental monitoring. VIDIA has its own research and development department that closely cooperates with The Academy of Sciences of the Czech Republic, hospitals and universities. The company has also peptide and conjugate synthesis laboratory.
View All Vidia Products
High Quality for The Correct Results
All VIDIA products go through multi–stage quality control process during manufacturing and the performance of kits is validated in the National reference laboratories. VIDIA uses the international External Quality Assurance, INSTAND (Germany) and Labquality (Finland) program to improve its diagnostic kits laboratory performance. Since 2003 the company is certified according to ISO 9001 and ISO 13485. All IVD products are CE certified. The products are designed to have high stability and long shelf life and to be easy to use.
Qualitative and semiquantitative colormetric detection of targeted biomarkers for autoimmune disease and cancer screening.
Quantifiable immunoassay detection of broad range of disease markers for Gastrointestinal and Respiratory infections for acute and chronic phase infections.
Detection of infectious serology by IgA, IgG and IgM with unified incubation times determination for all types of microbes, viruses and parasites.
Provides ready to use HRP conjugates and controls offering guaranteed stability, high sensitivity, and reproducibility analysis.
Determination in human plasma and serum samples to improve point of care analysis in all research and healthcare settings.
Immunofluorescence (IF) assay enables clear differentiation and localisation of wide variety of antigens in different types of biological tissues.
IF assays are useful determinants for qualitative analysis of various virus serology for Herpesviruses associated diseases for different stages of infection (EBV, VCA-EBV, EA EBV, HSV1&2, VZV, HHV6).
IF is an alternative assay result conformation for other immunosorbent analysis.
One step immunochromatographic assays offer qualitative detection of a variety of viral and bacterial antigens in human samples
Test kits are validated for diagnosis of gastro-intestinal infections and respiratory infections
Faster approach to tumour and inflammatory marker detection for haemoglobin, transferrib, lactoferrin, calprotectin using stool samples in healthcare settings
Depending on the specified antigen the specimens are taken as nose/throat swabs, lavages, aspirations, urine and stool samples offering fast and efficient qualitative analysis
Simple to use protocol offering quick results within 15 minutes, and no Laboratory equipment needed.
| Mono VIDITEST Range | |
|---|---|
| anti-CMV IgG | KZ-130-12 |
| anti-CMV IgM | KZ-131-12 |
| anti-CMV IgA | KZ-132-12 |
| anti-CMV IgG avidity | KZ-153-12 |
| anti-VCA EBV IgG | KZ-100-12 |
| anti-VZV IgG | KZ-150-12 |
| anti-VZV IgM | KZ-151-12 |
| anti-VZV IgG avidity | KZ-153-12 |
| anti-HSV1+2 IgG | KZ-140-12 |
| anti-HSV1+2 IgM | KZ-141-12 |
| anti-HSV1+2 IgA | KZ-142-12 |
| anti-HHV-6 IgG | KZ-160-12 |
| anti-HHV-6 IgM | KZ-161-12 |
| anti-Borrelia recomb. IgG + VlsE | KZ-300-12 |
| anti-Borrelia recomb. IgM | KZ-301-12 |
| anti-TBEV IgG | KZ-310-12 |
| anti-TBEV IgM | KZ-311-12 |
| anti-Mycoplasma pneumoniae IgG | KZ-400-12 |
| anti-Mycoplasma pneumoniae IgM | KZ-401-12 |
| anti-Mycoplasma pneumoniae IgA | KZ-402-12 |
| anti-Chlamydia pneumoniae IgG | KZ-230-12 |
| anti-Chlamydia pneumoniae IgM | KZ-231-12 |
| anti-Chlamydia pneumoniae IgA | KZ-232-12 |
| anti-Chlamydia trachomatis IgG | KZ-220-12 |
| anti-Chlamydia trachomatis IgA | KZ-222-12 |
| anti-Toxoplasma gondii IgG | KZ-210-12 |
| anti-Toxoplasma gondii IgM | KZ-211-12 |
| anti-Toxoplasma gondii IgA | KZ-212-12 |
| anti-Toxoplasma gondii IgG avidity | KZ-213-12 |
